Coronado Biosciences Inc. (CNDO) announced the pricing of its underwritten public offering of 5 million shares of its common stock at a price to the public of $5.00 per share for gross proceeds to Coronado of $25.0 million.
Coronado said it expects to receive approximately $23.0 million in net proceeds from the offering, after deducting underwriting discount and estimated offering expenses.
The company also has granted the underwriters a 30-day option to purchase up to an aggregate of 750,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on June 27, 2012, subject to customary closing conditions.
Click here to receive FREE breaking news email alerts for Acacia Research Corporation and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com
Business News